Guru Ownership Trend
Guru Analysis for Cullinan Therapeutics, Inc. (CGEM)
Cullinan Therapeutics, Inc. (CGEM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $24.03 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $6.28 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 186.2%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 48.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Cullinan Therapeutics, Inc. (CGEM)
Major holders include Steven Cohen ($12.87 M), Cliff Asness ($5.13 M), Renaissance Technologies (RenTech) ($4.61 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.73 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $6.28 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CGEM. The total reported sell value was $4.37 M.
Yes, 1 managers opened new positions in CGEM, and 3 increased their existing holdings. The total reported buy value was $10.65 M.